302
Participants
Start Date
March 15, 2017
Primary Completion Date
July 4, 2018
Study Completion Date
August 6, 2018
Semaglutide
Semaglutide, gradually increased to 1.0 mg, injected once weekly under the skin (subcutaneously, s.c.) for 30 weeks
Placebo
Semaglutide placebo, gradually increased to 1.0 mg, injected once weekly under the skin (subcutaneously, s.c.) for 30 weeks
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Hamar
Novo Nordisk Investigational Site, Hoenefoss
Novo Nordisk Investigational Site, Stavanger
Novo Nordisk Investigational Site, Namsos
Novo Nordisk Investigational Site, Saint Stefan
Novo Nordisk Investigational Site, Smithtown
Novo Nordisk Investigational Site, Albany
Novo Nordisk Investigational Site, West Seneca
Novo Nordisk Investigational Site, Beaver
Novo Nordisk Investigational Site, Pittsburgh
Novo Nordisk Investigational Site, McMurray
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Chesapeake
Novo Nordisk Investigational Site, Greenville
Novo Nordisk Investigational Site, Gastonia
Novo Nordisk Investigational Site, Charlotte
Novo Nordisk Investigational Site, Charlotte
Novo Nordisk Investigational Site, Kinston
Novo Nordisk Investigational Site, Lawrenceville
Novo Nordisk Investigational Site, Edgewater
Novo Nordisk Investigational Site, Anniston
Novo Nordisk Investigational Site, Andalusia
Novo Nordisk Investigational Site, Lexington
Novo Nordisk Investigational Site, Troy
Novo Nordisk Investigational Site, Jefferson City
Novo Nordisk Investigational Site, Little Rock
Novo Nordisk Investigational Site, Norman
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, Sugar Land
Novo Nordisk Investigational Site, Victoria
Novo Nordisk Investigational Site, Shavano Park
Novo Nordisk Investigational Site, Austin
Novo Nordisk Investigational Site, Murray
Novo Nordisk Investigational Site, Phoenix
Novo Nordisk Investigational Site, Tempe
Novo Nordisk Investigational Site, Glendale
Novo Nordisk Investigational Site, Northridge
Novo Nordisk Investigational Site, La Jolla
Novo Nordisk Investigational Site, Lincoln
Novo Nordisk Investigational Site, Olympia
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Novosibirsk
Novo Nordisk Investigational Site, Barnaul
Novo Nordisk Investigational Site, Maitland
Novo Nordisk Investigational Site, Woodstock
Novo Nordisk Investigational Site, Hutchinson
Novo Nordisk Investigational Site, Morehead City
Novo Nordisk Investigational Site, Arlington
Novo Nordisk Investigational Site, Irving
Novo Nordisk Investigational Site, Edmonton
Novo Nordisk Investigational Site, Winnipeg
Novo Nordisk Investigational Site, Brampton
Novo Nordisk Investigational Site, Brampton
Novo Nordisk Investigational Site, Etobicoke
Novo Nordisk Investigational Site, Smiths Falls
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Waterloo
Novo Nordisk Investigational Site, Kanagawa
Novo Nordisk Investigational Site, Nagakute-shi, Aichi
Novo Nordisk Investigational Site, Suita-shi, Osaka
Novo Nordisk Investigational Site, Tokyo
Novo Nordisk Investigational Site, Olso
Novo Nordisk Investigational Site, Oslo
Novo Nordisk Investigational Site, Skedsmokorset
Novo Nordisk Investigational Site, Ponce
Lead Sponsor
Novo Nordisk A/S
INDUSTRY